Petosemtamab
2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Petosemtamab for laryngeal diseases | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Petosemtamab for squamous cell carcinoma of head and neck | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 3 |